Biomet Inc
Article Abstract:
Biomet Inc manufactures and markets joint reconstruction implants, electric bone growth stimulators and other medical products. Insider selling was observed in Sep 1992 despite low prices, indicating some negative developments. The stock was trading at $21 during that period and eventually dropped to the current $13 level. Six insiders disposed of 201,100 shares last Nov and Dec 1992 at the $15.50 to $16.75 range. Therefore, caution is suggested for the stock.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Amgen Inc
Article Abstract:
Biotechnology firm Amgen Inc develops human health care products. Seven insiders disposed of more than 180,000 shares last Sum 1992 at the $57 to $67 price range. The sales increased substantially during the Nov and Dec 1992 rally when 10 insiders got out of 367,580 shares at the $66 to $76 level. The sales of non-option related shares also exceeded option-related ones. The sales were observed during both price rises and declines so caution is suggested.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Calgene Inc
Article Abstract:
The share price of Calgene Inc has undergone a deterioration since its $20 peak in Jan 1993, reaching a low of $10 by Apr 1993. Analysts have observed a significant level of selling, and four insiders recently disposed of 16,854 shares at prices ranging from $10 to $14. The continued selling activity is a matter of concern.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1993
User Contributions:
Comment about this article or add new information about this topic: